It never ceases to amaze me that people think there is a "right" answer to this question. Much depends on the overall organization structure, the engagement of the President of CEO with QA/RA matters, and the dynamics between groups. Over the years, I have been in RA organizations that reported through legal, through quality, straight to the GM or President, through the COO etc. Similarly, for quality I reported to legal, to the President, the COO, the CEO and the CTO. They all had different strengths and weaknesses, more related to the individuals than the org structure.
For example, by far the best leader I reported to, and the most dedicated to "doing things right" was an R&D guy who had evolved into our COO. Yes, he had charge of operations and R&D, but that was a positive, not a negative. We also had a super-engaged President at that time. Similarly, given my background, I think that even as CTO, having RA report to me is reasonable.
I can tell you what DOESN'T work.
- a top QA/RA leader who isn't able to influence and get things done without their boss having to make people agree
- reporting through a functional leaders (Ops, R&D whoever) that has an agenda that does not include doing things right
- having top management that doesn't give a [blank] about QA/RA/Compliance
g-
------------------------------
Ginger Glaser RAC
Chief Technology Officer
MN
------------------------------
Original Message:
Sent: 05-Mar-2018 05:39
From: Anonymous Member
Subject: QM & QA reporting lines
This message was posted by a user wishing to remain anonymous
Dear community,
I been confronted over and over again with the question where QM/QA should report into in a medtech company (especiall in a low risk class I, II (mostly without 510(k)s)).
It would be great if you could share some thought or experience on this?
thank you